Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,694 JPY | -3.60% | +3.67% | +16.79% |
May. 15 | Correction: Terumo’s Profit Up 47% in Fiscal 2024 | MT |
May. 15 | Terumo’s Profit Up 47% in Fiscal 2023 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 38.54 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 4.61 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.79% | 25.99B | A- | ||
-4.72% | 182B | C+ | ||
+3.96% | 112B | C | ||
-2.93% | 68.58B | A | ||
+6.30% | 51.58B | B- | ||
+8.02% | 44.24B | B- | ||
+7.91% | 43.65B | B+ | ||
+26.18% | 32.46B | B | ||
+0.57% | 25.61B | A- | ||
-0.38% | 24.89B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4543 Stock
- Ratings Terumo Corporation